Repros Therapeutics Inc Stock

Stocks

27/01/18	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
16/12/17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
13/12/17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
13/12/17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
12/12/17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

02/04/15	Apple : Les valeurs à suivre sur les marchés américains
02/04/15	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
WUXI APPTEC CO., LTD.	-2.43%	-7.34%	+36.10%	+58.44%	62.23B
ARGENX SE	+0.61%	+1.10%	+11.79%	+70.22%	54.92B
LONZA GROUP AG	+0.62%	+2.74%	+17.68%	+103.81%	55.26B
IQVIA HOLDINGS INC.	+1.61%	-4.02%	+21.31%	+37.87%	42.59B
BEONE MEDICINES AG	-1.74%	-4.28%	+14.34%	+95.00%	41.08B
REVOLUTION MEDICINES, INC.	+3.22%	+5.62%	+230.10%	+818.35%	40.33B
GENMAB A/S	+0.57%	+25.47%	+102.34%	+88.40%	33.12B
CELLTRION, INC.	-1.09%	-0.05%	+13.55%	+45.35%	32.61B
INSMED INCORPORATED	-4.46%	+11.90%	-44.92%	+317.59%	23.98B
Average	-0.31%	+3.75%	+44.70%	+181.67%	42.9B
Weighted average by Cap.	-0.21%	+2.11%	+45.07%	+165.17%

Employees

Sector